11.03.2015 Views

Intravenous TAMIFLU

Intravenous TAMIFLU

Intravenous TAMIFLU

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

COMPASSIONATE USE – CU 056<br />

<strong>Intravenous</strong> <strong>TAMIFLU</strong> ® (oseltamivir)<br />

Both, the paper version and the electronic version of the yellow form can be<br />

downloaded from the following website link: http://www.fagg-afmps.be.<br />

(French: Usage humain/Pharmacovigilance – Collecte des données…)<br />

(Dutch: Menselijk gebruik /Geneesmiddelenbewaking – Gegevens verzamelen…)<br />

2. NV Roche SA, by means of the Spontaneous Adverse Event fax cover sheet and<br />

Adverse Event form provided in the CU file.<br />

This form should be sent by fax to NV Roche SA Drug Safety Brussels (fax:<br />

02/525.84.66).<br />

Details on requirements and timelines of safety reporting to NV Roche SA can be<br />

found in the section 'Physician's commitments (§ 6, 7, 8)', which is part of the<br />

Physician Request Form.<br />

Oseltamivir IV is restricted to medical prescription on a compassionate use basis.<br />

Compassionate Use 056 – <strong>Intravenous</strong> Tamiflu ® (oseltamivir) - Version 20 December<br />

2011<br />

14/15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!